Spiperone, a dopamine antagonist widely used as a specific ligand for dopamine and serotonin receptors, is actively accumulated into the F4C1 strain of rat pituitary tumor cells. The accumulation of 10 nM [3Hjspiperone was linear for 3 min and reached a steady state after 10 min. Spiperone accumulation was reduced 50% by preincubation with 5 jiM reserpine, an inhibitor of biogenic amine transport into secretory granules, and was also blocked by monensin and ammonium chloride, both of which increase the pH of intracellular storage organelles. Uptake was not affected by replacing sodium in the buffer with lithium at equimolar concentrations.
Prolactin production by the anterior pituitary gland in the rat is primarily under negative control by the hypothalamus (1) . At least part of the inhibition of prolactin secretion appears to be caused by dopamine released from the hypothalamus. Dopamine acts directly on the anterior pituitary gland to inhibit prolactin production (2) , and measurements of dopamine in the portal blood system connecting the hypothalamus to the anterior pituitary gland have shown that the concentration is sufficient to cause significant inhibition of prolactin release (3).
The pituitary gland contains dopamine-binding sites, and the relative affinities of agents for these sites correlate with their relative abilities to inhibit prolactin release (4, 5) .
[3H]Spiperone, a dopaminergic antagonist, has been used to estimate the distribution of these binding sites (6) . This compound is also used frequently to measure both dopaminergic and serotonergic receptors in the brain (7, 8) . The pituitary gland is a heterogeneous population of cell types; studies of biochemical mechanisms of dopaminergic action are, therefore, difficult to interpret. We have been screening pituitary cell lines for the presence of dopamine receptors, to have a pure population of prolactin-producing cells. During the course of these investigations we found evidence that suggests a prolactin-producing tumor cell strain, F4, may accumulate [3H]spiperone by a transport system similar to that found in secretory granules and synaptic vesicles and distinct from binding to dopamine receptors.
METHODS
Materials. [benzene ring-3H]Spiperone was obtained from New England Nuclear, with a specific activity of 19.9 Ci/ mmol, or Amersham, with a specific activity of 16 Ci/mmol (1 Ci = 37 GBq). Monensin and reserpine were from Calbiochem. Benztropine was from Merck, Sharp and Dohme.
Cell Culture. The F4C1 cell strain is a clonal cell line from a rat pituitary tumor that makes prolactin and growth hormone (9) . The cells were obtained from Ingrid Richardson (Harvard School of Public Health). They were cultured on 35-mm plates in 1.0 ml of 1:1 mixture of Dulbecco's minimal essential medium and Ham's nutrient mixture F10 plus 15% horse serum. Cultures were maintained in a humidified atmosphere of 95% air/5% CO2 at 37°C. Cells were cultured at a density of 5 x 104 cells per plate. The medium was changed 2 days later, and uptake experiments were performed the next day.
[3H]Spiperone Uptake. Unless otherwise indicated, the plates were rinsed twice at the start of the experiment with 1 ml of buffer per rinse. Buffer used for the uptake experiments contained 120 mM NaCl, 5 mM Hepes, 5 mM KCl, 2 mM MgCl2, and 10 mM glucose, pH 7.2. After rinsing, the cells were incubated at 37°C with 1 ml of buffer containing [3H]spiperone and other drugs as indicated. The uptake period was ended by rinsing the cells three times with cold saline and then dissolving the cells in 1.0 ml of 0.1 M NaOH. The radioactivity of a 0.4-ml aliquot was measured in Biofluor scintillation fluid (New England Nuclear), and 0.4 ml was used to determine cell number or protein content. Protein determinations were more easily reproducible than cell counts and were routinely used; we found that 1 mg of protein is equivalent to 9 x 105 cells and used this factor to convert protein to cell number. Protein was determined by the Lowry technique (10), using bovine serum albumin as a standard.
Prolactin Determinations. Prolactin was assayed by microcomplement fixation as described (11) .
Serotonin Transport Assays. Serotonin transport into membrane vesicles isolated from platelet dense granules was measured at 37°C as described (12) . Transport into platelet plasma membrane vesicles was measured at 25°C as described (13) . RESULTS F4C1 Cells Take Up Spiperone. Data in Fig. 1 show the uptake of 10 nM [3H]spiperone into F4C1 cells. The accumulation was linear in this and other experiments for at least 3 min; after this time the rate of accumulation decreased. In other experiments we have found accumulation at the end of 1 hr was no greater than after 10 min of incubation. Characteristics of this uptake were different than those of spiperone binding to the dopaminergic plasma membrane receptors. First, binding to these receptors is half-maximally saturated at concentrations less than 1 nM (6), but uptake of [3H]spiperone into F4C1 cells was proportional to the amount of [3H]spiperone in the medium to concentrations of at least 30 nM (Fig. 2) . Second, 10 ,uM dopamine and 3 nM bromocriptine, a dopaminergic agonist, inhibited binding of 1 nM
[3H]spiperone to the dopaminergic receptor by more than 50% (6) . We found the uptake of 0. ranging from 1 to 400 ,uM or by bromocriptine in concentrations ranging from 4 nM to 1 AM (data not shown). Therefore the uptake of spiperone is not caused by binding to the previously characterized membrane receptor.
Characterization of Uptake. Two types of amine transport systems have been characterized in neurons and other secretory cells. Na+-dependent plasma membrane transporters are specific for the transported substrate and are inhibited by compounds such as benztropine (14) and imipramine (15) . Granule transporters are driven by the transmembrane H+ gradient, are less specific, and are inhibited by reserpine (16) . Replacing sodium in the buffer with lithium did not affect [3H]spiperone uptake by F4C1 cells (Fig. 3) . Uptake was markedly affected only at 10 lM benztropine (Table 1) , a concentration that is high compared to concentrations of less than 1 AM that inhibit the plasma membrane dopamine transport system (14) .
Reserpine inhibits amine uptake by the transport system in secretory vesicles (16) . Reserpine at 5 ,u M also inhibits accumulation of [3H]spiperone into F4C1 cells by 50% (Fig. 4) . -Amine transport into secretory vesicles is driven by a pH gradient. Thus two agents that destroy this gradient, monensin and ammonium chloride, inhibit amine transport (17 F4C1 cells (Fig. 5) ; 10 mM NH4Cl and 10 ,uM monensin each cause over 50% inhibition of uptake. Reserpine, monensin, and ammonium chloride do not appear to act by toxic effects on the cells for two reasons: first, there is no effect on cell number or the amount of cell protein during the period the cells are incubated with these agents, and second, there is little effect on cell protein and prolactin accumulation in the medium 4 days after treatment with these agents (Table 2) .
To further test the possibility that spiperone interacts with the transport system in secretory granules, we measured the ability of spiperone to inhibit serotonin transport into membrane vesicles isolated from platelet dense granules. These vesicles accumulate serotonin to high internal concentrations when supplied with ATP as an energy source. This accumulation is sensitive to inhibition by reserpine and uncouplers, indicating that it is a good model of biogenic amine accumulation in many secretory granules (12, 18) . As shown in Fig. 6 , spiperone is a potent inhibitor of this serotonin transport system. Transport is more than 50% inhibited at 1 ,M spiperone and almost completely blocked at 5 ,uM.
As a control, we tested spiperone's ability to inhibit serotonin transport into platelet plasma membrane vesicles. This transport system is insensitive to reserpine or ATP but is driven by transmembrane gradients of Na+, K+, and Cland is blocked by imipramine (18) . As shown in Fig. 6 F4C1 cells spiperone apparently diffuses through the plasma membrane and then is transported into the secretory granules by a biogenic amine transport system. Diffusion back through the secretory granule membranes of F4C1 cells must not occur as rapidly as transport into the vesicles, since we detect accumulation. F4C1 cells evidently lack functional plasma membrane amine transport systems for dopamine or serotonin, since we did not detect sodium-dependent dopamine or serotonin uptake into these cells (unpublished results). Therefore we could not test in these intact cells whether spiperone could inhibit amine transport. We did, however, demonstrate that spiperone directly inhibits serotonin uptake into vesicles isolated from platelet granules. Although platelet granule vesicles fail to accumulate spiperone (data not shown) this may be due to faster efflux from these vesicles than from F4C1 granules.
Fujita et al. (19) 0.040 ± 0.007 Cells were rinsed and treated with the compounds in buffer, using the same procedure as we used to inhibit spiperone uptake (30 min of incubation with reserpine and 2 min with monensin and ammonium chloride). Then the buffer was replaced with medium and the cells were grown for 4 days. Medium was collected and prolactin in the medium was measured. Each value is the mean ± SD of triplicate plates.
neurons is that prolactin cells have spontaneous action potentials (20) ; agents that trigger release of prolactin can stimulate an increase in the frequency of these action potentials, while agents that inhibit prolactin release inhibit generation of these potentials. The reserpine-sensitive spiperone uptake in the F4C1 cells indicates that these pituitary tumor cells may share another trait with neurons, the biogenic amine transport system of the secretory vesicles.
Normal prolactin-producing cells may have both the plasma membrane and the granule membrane transport system. The reason for suggesting normal cells may have both systems is that Porter and co-workers have demonstrated [3H]dopamine accumulation in intact cells; the dopamine was found in a fraction with the same density as a fraction that contained the majority of the intracellular prolactin (21) . They therefore suggested dopamine was accumulating in the secretory granules. Because they found that 15 uM cis-flupenthixol (a dopaminergic antagonist) and 10 ,uM perebedil (an agonist) prevented the accumulation of dopamine, they suggested that the accumulation was a receptor-mediated event (22) . If, however, dopaminergic agents also compete with dopamine for uptake into granules, then dopamine accumulation would be decreased. We suggest that dopamine accumulation in the pituitary gland may be inhibited by agents that inhibit the granule transport system. 
